CORONA Remedies

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue363.40344.66357.20425.58443.65
Expenses293.79270.37302.74345.23363.03
EBITDA80.7485.4066.1396.2898.43
EBIT71.7156.8756.1283.0583.50
Profit Before Tax69.7855.2154.7480.3680.75
Net Profit52.3241.2745.3360.1160.31
Financial Ratios
Operating Profit Margin22.40%19.37%18.81%22.79%22.34%
Net Profit Margin14.49%15.90%12.84%14.23%13.67%
Earning Per Share (Diluted)8.556.757.419.839.86
Dividends Per Share0.000.000.000.000.00